HLA-DRB1 ChainsHLA-DQ beta-ChainsOligoclonal BandsHLA-DR AntigensHLA AntigensHLA-DRB3 ChainsHLA-DQ AntigensHLA-DQ alpha-ChainsLithuaniaAllelesMultiple SclerosisGene FrequencyGenetic Predisposition to DiseaseHaplotypesGenotypePolymerase Chain ReactionGenetic Association StudiesDichlororibofuranosylbenzimidazoleHLA-B AntigensHistocompatibility TestingEvoked Potentials, VisualHLA-A AntigensMolecular Sequence DataHLA-DRB4 ChainsGenes, MHC Class IIHLA-DRB5 ChainsImmunoglobulin Light ChainsImmunoglobulin Heavy ChainsAmino Acid SequenceHLA-DR4 AntigenHLA-DR Serological SubtypesHLA-DP beta-ChainsDNA Probes, HLAHistocompatibility Antigens Class IHistocompatibility Antigens Class IIMyosin Heavy ChainsBase SequenceHLA-D AntigensHLA-C AntigensHLA-DR3 AntigenHLA-DR beta-ChainsMyosin Light ChainsHLA-DR2 AntigenReverse Transcriptase Polymerase Chain ReactionPolymorphism, GeneticEpitopesBahrainGenes, MHC Class IHistocompatibilityPeptide FragmentsHLA-B44 AntigenMajor Histocompatibility ComplexRNA, MessengerEpitopes, T-LymphocyteDiabetes Mellitus, Type 1Cell LinePeptidesProtein BindingHLA-DP AntigensHLA-B7 AntigenMutationModels, MolecularDNA PrimersRibonucleosidesArthritis, RheumatoidHLA-DR5 AntigenKineticsT-LymphocytesProtein ConformationHLA-B27 AntigenLinkage DisequilibriumBinding SitesCase-Control StudiesAutoantibodiesDisease SusceptibilityHLA-A2 AntigenHLA-DR1 AntigenMyosinsAntigen PresentationCells, CulturedHLA-DR7 AntigenPhenotypeDNAMacromolecular SubstancesCloning, MolecularHLA-B8 AntigenTissue DonorsB-LymphocytesGenetic VariationClone CellsImmunoglobulin kappa-ChainsAntibodies, MonoclonalRecombinant Proteinsbeta 2-MicroglobulinHLA-DR alpha-ChainsHLA-A1 AntigenMolecular WeightElectrophoresis, Polyacrylamide GelT-Lymphocytes, CytotoxicGene Rearrangement, B-Lymphocyte, Light Chain